Labetuzumab
CAS: 219649-07-7
Ref. TM-T9901A-004
| 1mg | 327.00 € | ||
| 2mg | 449.00 € | ||
| 5mg | 655.00 € | ||
| 10mg | 1,027.00 € | ||
| 25mg | 1,563.00 € | ||
| 50mg | 2,100.00 € | ||
| 100mg | 2,778.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Product Information
Name:
Labetuzumab
Synonyms:
- IMMU-14
- hMN-14
- IMMU-100
- Antibody hMN 14
- Immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 γ-chain), disulfide with human-mouse monoclonal hMN-14 κ-chain, dimer
Description:
Labetuzumab (hMN-14) is an anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity for the study of thyroid and colorectal cancer .
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
145.1 kDa
Purity:
SDS-PAGE: 95.2%；SEC-HPLC: 95.6%
Color/Form:
Soild
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T9901A-004 Labetuzumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
